Related Experiment Video
Updated: May 13, 2026

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
Published on: November 11, 2021
Mdm2 increases cellular invasiveness by binding to and stabilizing the Slug mRNA
Chan-Hun Jung1, Jongdoo Kim, Jong Kuk Park
1Division of Radiation Cancer Biology, Korea Institute of Radiological & Medical Sciences, Seoul 139-706, Republic of Korea.
Abstract:
Mdm2 is an oncoprotein that induces the degradation of the tumor suppressor, p53. Here, we show that Mdm2 increases the mRNA levels of Slug by binding to and stabilizing the Slug mRNA. While this effect of Mdm2 was observed in both p53-null and p53-expressing cancer cells, it increased the protein levels of Slug only in the former cells. Mdm2 consistently induced Slug-dependent events, such as decreases in E-cadherin levels and increases in cellular invasiveness, only in p53-null cells. Therefore, the binding of Mdm2 to the Slug mRNA appears to provide a novel mechanism through which Mdm2 promotes tumor progression in a manner independent of the presence of p53.
Insights
The Mdm2 oncoprotein stabilizes Slug mRNA, promoting cancer progression. This Mdm2-Slug interaction enhances tumor invasiveness, particularly in p53-null cancer cells, revealing a p53-independent mechanism.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Mdm2 is an oncoprotein that targets the tumor suppressor p53 for degradation.
- The regulation of tumor suppressor proteins and oncogenic pathways is crucial in cancer progression.
Purpose of the Study:
- To investigate the role of Mdm2 in regulating Slug mRNA and protein levels.
- To determine if Mdm2-mediated Slug regulation impacts cancer cell behavior independently of p53.
Main Methods:
- Analysis of mRNA and protein levels of Slug in cancer cells with and without p53.
- Assessment of Mdm2's binding to Slug mRNA.
- Evaluation of Slug-dependent cellular events like E-cadherin levels and invasiveness.
Main Results:
- Mdm2 binding to Slug mRNA increases its stability and mRNA levels in both p53-null and p53-expressing cells.
- Mdm2 elevates Slug protein levels exclusively in p53-null cancer cells.
- Mdm2 induces Slug-dependent decreases in E-cadherin and increases in cellular invasiveness, but only in p53-null cells.
Conclusions:
- Mdm2 stabilizes Slug mRNA, representing a novel mechanism for Mdm2 to promote tumor progression.
- This Mdm2-Slug interaction drives cancer progression independently of p53 status, highlighting a potential therapeutic target in p53-null cancers.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
